Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.72 |
| ▸ | MAPT | P10636 | 6/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 4/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | EGFR | P00533 | 4/20 | 0.44 |
| ▸ | IGF1R | P08069 | 4/20 | 0.44 |
| ▸ | FLT4 | P35916 | 4/20 | 0.44 |
| ▸ | KDR | P35968 | 4/20 | 0.44 |
| ▸ | HPGD | P15428 | 4/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | CASP7 | P55210 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29386410 | 1.00 | KDM4E (0.72) | KDM4EALDH1A1MAPTNPC1NCOA1 | |
| SCHEMBL15396798 | 0.91 | KDM4E (0.62) | KDM4EALDH1A1MAPTNPC1NCOA1 | |
| SCHEMBL30863308 | 0.84 | KDM4E (1.00) | KDM4EALDH1A1MAPTNPC1NCOA1 | |
| SCHEMBL2521419 | 0.84 | KDM4E (1.00) | KDM4EALDH1A1MAPTNPC1NCOA1 | |
| SCHEMBL30947375 | 0.84 | KDM4E (1.00) | KDM4EALDH1A1MAPTNPC1NCOA1 | |
| SCHEMBL11884983 | 0.84 | KDM4E (0.55) | KDM4EALDH1A1MAPTNPC1NCOA1 | |
| SCHEMBL15855373 | 0.82 | KDM4E (0.53) | KDM4EALDH1A1MAPTNPC1NCOA1 | |
| SCHEMBL15855349 | 0.82 | KDM4E (0.53) | KDM4EALDH1A1MAPTNPC1NCOA1 | |
| SCHEMBL15855351 | 0.82 | KDM4E (0.53) | KDM4EALDH1A1MAPTNPC1NCOA1 | |
| SCHEMBL15855350 | 0.82 | KDM4E (0.53) | KDM4EALDH1A1MAPTNPC1NCOA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 243 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250250483-A1 | ORGANOMETALLIC COMPLEX AND LIGHT-EMITTING DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2025-08-07 | — | — | US | claimed |
| US-20160093818-A1 | Organometallic Complex, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-03-31 | — | — | US | claimed |
| US-20090076268-A1 | Facile assembly of fused benzofuro-heterocycles | JANSSEN PHARMACEUTICA N.V. (BE) | 2009-03-19 | — | — | US | claimed |
| WO-2009035668-A1 | FACILE ASSEMBLY OF FUSED BENZOFURO-HETEROCYCLES | JANSSEN PHARMACEUTICA N.V. (BE) | 2009-03-19 | — | — | WO | claimed |
| US-20260123268-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2026-04-30 | — | — | US | disclosed |
| US-12565613-B2 | Quantum dots with donor-acceptor ligands | SHOEI CHEMICAL INC. (JP) | 2026-03-03 | — | — | US | disclosed |
| US-12448392-B2 | Spiropiperidine derivatives | CEPHALON LLC (US) | 2025-10-21 | — | — | US | disclosed |
| US-12441702-B2 | Substituted 4-benzyl and 4-benzoyl piperidine derivates | CEPHALON LLC (US) | 2025-10-14 | — | — | US | disclosed |
| US-20250257035-A1 | 1,4-Substituted Piperidine Derivatives | CEPHALON LLC | 2025-08-14 | — | — | US | disclosed |
| US-20250250483-A1 | ORGANOMETALLIC COMPLEX AND LIGHT-EMITTING DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2025-08-07 | — | — | US | disclosed |
| US-20250126968-A1 | Light-Emitting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2025-04-17 | — | — | US | disclosed |
| US-20240381687-A1 | DISPLAY APPARATUS, DISPLAY MODULE, AND ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-11-14 | — | — | US | disclosed |
| WO-2006081973-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2006-08-10 | — | — | WO | disclosed |
| US-20060173026-A1 | 8-N-substituted-2H-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents | ACHILLION PHARMACEUTICALS, INC. | 2006-08-03 | — | — | US | disclosed |
| WO-2006074317-A1 | 1-THIA-2,4A-DIAZA-CYCLOPENTA[B]NAPHTHALENE-3,4-DIONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTS | ACHILLION PHARMACEUTICALS, INC. (US) | 2006-07-13 | — | — | WO | disclosed |
| EP-1664062-A1 | ISOTHIAZOLOQUINOLONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTS | Achillion Pharmaceuticals, Inc. (US) | 2006-06-07 | — | — | EP | disclosed |
| US-20060100215-A1 | 8A,9-dihydro-4aH-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents | ACHILLION PHARMACEUTICALS, INC. | 2006-05-11 | — | — | US | disclosed |
| US-20050075363-A1 | Isothiazoloquinolones and related compounds as anti-infective agents | ACHILLION PHARMACEUTICALS, INC. | 2005-04-07 | — | — | US | disclosed |
| WO-2005019228-A1 | ISOTHIAZOLOQUINOLONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTS | ACHILLION PHARMACEUTICALS, INC. (US) | 2005-03-03 | — | — | WO | disclosed |
| US-5274100-A | Process for the preparation of (3-fluoropyridin-2-yloxy)phenoxypropionic acids | CIBA-GEIGY CORPORATION (US) | 1993-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250257035-A1 | 1,4-Substituted Piperidine Derivatives | FASN, CES1, CPT1A | KDM4E 1054/4885ALDH1A1 110/4885MAPT 3799/4885 |
| US-12441702-B2 | Substituted 4-benzyl and 4-benzoyl piperidine derivates | FASN, CES1, FADS2 | KDM4E 536/4885ALDH1A1 106/4885MAPT 3856/4885 |
| US-12565613-B2 | Quantum dots with donor-acceptor ligands | HCCS, FDPS, FTH1 | KDM4E 4066/4885ALDH1A1 125/4885MAPT 3930/4885 |
| US-20050075363-A1 | Isothiazoloquinolones and related compounds as anti-infective agents | TOP1, IRF3, RECQL | KDM4E 2795/4885ALDH1A1 2406/4885MAPT 4593/4885 |
| US-20060173026-A1 | 8-N-substituted-2H-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents | TOP1, TOP2A, DNA2 | KDM4E 3682/4885ALDH1A1 1042/4885MAPT 4670/4885 |
| US-20260123268-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | GLRA1, LBR, GLRB | KDM4E 4108/4885ALDH1A1 1949/4885MAPT 4497/4885 |
| US-20250250483-A1 | ORGANOMETALLIC COMPLEX AND LIGHT-EMITTING DEVICE | CRY1, CRY2, RPS23 | KDM4E 3513/4885ALDH1A1 1497/4885MAPT 3617/4885 |
| US-20090076268-A1 | Facile assembly of fused benzofuro-heterocycles | BICRA, DDC, DDT | KDM4E 1620/4885ALDH1A1 739/4885MAPT 1787/4885 |
| US-12448392-B2 | Spiropiperidine derivatives | FASN, FADS2, SCD5 | KDM4E 3729/4885ALDH1A1 128/4885MAPT 4291/4885 |
| US-20160093818-A1 | Organometallic Complex, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | GPS1, AP1M1, AP3M1 | KDM4E 2914/4885ALDH1A1 999/4885MAPT 3880/4885 |
| US-20060100215-A1 | 8A,9-dihydro-4aH-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents | RECQL, DNA2, REV1 | KDM4E 2575/4885ALDH1A1 1263/4885MAPT 4329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.